Diene S M, Bertelli C, Pillonel T, Schrenzel J, Greub G
Institut de microbiologie, CHUV, Université de Lausanne, Lausanne.
Rev Med Suisse. 2014 Nov 12;10(450):2155-61.
New sequencing technologies provide in a short time and at low cost high amount of genomic sequences useful for applications such as: a) development of diagnostic PCRs and/or serological tests; b) detection of virulence factors (virulome) or genes/SNPs associated with resistance to antibiotics (resistome) and c) investigation of transmission and dissemination of bacterial pathogens. Thus, bacterial genomics of medical importance is useful to clinical microbiologists, to infectious diseases specialists as well as to epidemiologists. Determining the microbial composition of a sample by metagenomics is another application of new sequencing technologies, useful to understand the impact of bacteria on various non-infectious diseases such as obesity, asthma, or diabetes. Genomics and metagenomics will likely become a specialized diagnostic analysis.
新的测序技术能在短时间内以低成本提供大量基因组序列,这些序列可用于以下应用:a)诊断性聚合酶链反应(PCR)和/或血清学检测的开发;b)毒力因子(毒力组)或与抗生素耐药性相关的基因/单核苷酸多态性(耐药组)的检测;c)细菌病原体传播和扩散的调查。因此,具有医学重要性的细菌基因组学对临床微生物学家、传染病专家以及流行病学家都很有用。通过宏基因组学确定样本的微生物组成是新测序技术的另一应用,有助于理解细菌对各种非传染性疾病(如肥胖症、哮喘或糖尿病)的影响。基因组学和宏基因组学很可能会成为一种专门的诊断分析方法。